Haematologica | 2018
Tocilizumab, tacrolimus and methotrexate for the prevention of acute graft-versus-host disease: Low incidence of lower gastrointestinal tract disease.
Drobyski WR, Szabo A, Zhu F, Keever-Taylor C, Hebert KM, Yim S, Johnson B, D'Souza A, Eapen M, Fenske TS, Hari P, Hamadani M, Horowitz MM, Rizzo JD, Saber W, Shah N, Shaw B, Pasquini M
PubMed
PMID: 29351985
Abstract
Related Articles
CIBMTR Study #: SC16-04a